Biomea Fusion, Inc. (BMEA) Insider Trading & SEC Filings
Last SEC filing
Biomea Fusion, Inc. (BMEA) has filed 4 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-12. 2 Form 8-K material event filings were reported by BMEA in the last 90 days. InsiderAlpha tracks every BMEA SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About Biomea Fusion, Inc. (BMEA)
Biomea Fusion, Inc. trades under the ticker BMEA. InsiderAlpha tracks 15 primary SEC Form 4 filings from 8 reporting insiders for BMEA since 2024, sourced directly from SEC EDGAR.
| Sector | Health Care insider trading |
|---|---|
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
| SEC CIK | 0001840439 |
90-Day SEC Filing Activity
| Form 4 filings (90d) | 4 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Latest Form 4 filing | 2026-06-12 |
Recent BMEA Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Michael J.M. Hitchcock | Interim CEO | P - Open-market purchase | 100.0K | $0.99 | $99K | SEC | |
| Rainer M. Erdtmann | Insider | P - Open-market purchase | 10.0K | $1.05 | $10K | SEC | |
| Rainer M. Erdtmann | Insider | P - Open-market purchase | 40.0K | $1.10 | $44K | SEC | |
| Rainer M. Erdtmann | Insider | G - Bona-fide gift | 10.0K | $0.00 | - | SEC | |
| Rainer M. Erdtmann | Insider | G - Bona-fide gift | 10.0K | $0.00 | - | SEC | |
| Rainer M. Erdtmann | Insider | G - Bona-fide gift | 10.0K | $0.00 | - | SEC | |
| Rainer M. Erdtmann | Insider | G - Bona-fide gift | 10.0K | $0.00 | - | SEC | |
| Rainer M. Erdtmann | Insider | G - Bona-fide gift | 10.0K | $0.00 | - | SEC | |
| Rainer M. Erdtmann | Insider | G - Bona-fide gift | 10.0K | $0.00 | - | SEC | |
| Rainer M. Erdtmann | Insider | G - Bona-fide gift | 40.0K | $0.00 | - | SEC | |
| Franco Valle | Chief Financial Officer | A - Grant or award | 495 | $6.15 | $3K | SEC | |
| Michael J.M. Hitchcock | Insider | P - Open-market purchase | 10.0K | $10.06 | $101K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Biomea Fusion, Inc. (BMEA). Updated in real time as new filings are submitted to the SEC.
Most-Active BMEA Insiders - Last 90 Days
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Julianne Averill | 1 | - |
| Eric Aguiar | 1 | - |
| Elizabeth Faust | 1 | - |
| Sumita Ray | 1 | - |
Recent BMEA Form 8-K Material Events
- - Item 5.07 [SEC]
- - Item 2.02, 9.01 [SEC]
- - Item 7.01, 8.01, 9.01 [SEC]
- - Item 2.02, 9.01 · Earnings · neutral [SEC]
Biomea Fusion issued a press release on March 24, 2026 announcing its financial results for Q4 2025 and full year 2025. The filing provides standard quarterly and annual financial results without explicit beat/miss or guidance language. - - Item 7.01, 9.01 · Other · neutral [SEC]
Biomea Fusion updated its corporate presentation for investor and analyst use and posted it to its website. This is a routine disclosure filing under Regulation FD with no substantive business, clinical, financial, or strategic announcements. The presentation itself is not attach
Recent Insider Filings
- - Elizabeth Faust (Insider)
- - Eric Aguiar (Insider)
- - Sumita Ray (Insider)
- - Julianne Averill (Insider)
- - Rainer M. Erdtmann (Insider)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in BMEA insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
BMEA Insider Trading - FAQ
- What is the latest insider trade for BMEA?
- Biomea Fusion, Inc. (BMEA) had 4 insider filings in the last 90 days, with the most recent on 2026-06-12. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying BMEA stock?
- 0 insider purchases of BMEA were filed in the last 90 days.
- How many insiders are selling BMEA stock?
- 0 insider sales of BMEA were filed in the last 90 days.
- Where can I see BMEA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks BMEA Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $CADL Candel Therapeutics, Inc.
- $CAMP Camp4 Therapeutics Corp
- $CARL CARLSMED, INC.
- $CBIO CRESCENT BIOPHARMA, INC.
- $CBLL Ceribell, Inc.
- $CELU Celularity Inc
- $CGEM Cullinan Therapeutics, Inc.
- $CGON CG Oncology, Inc.
- $CLRB Cellectar Biosciences, Inc.
- $COCH Envoy Medical, Inc.
Related Companies - Recent Insider Activity
- UNITED THERAPEUTICS Corp (UTHR)
- Liquidia Corp (LQDA)
- BeOne Medicines Ltd. (ONC)
- PERRIGO Co plc (PRGO)
- Processa Pharmaceuticals, Inc. (PCSA)
- Nuvalent, Inc. (NUVL)
- CYTOKINETICS INC (CYTK)
- Elanco Animal Health Inc (ELAN)
- Avalo Therapeutics, Inc. (AVTX)
- NATURES SUNSHINE PRODUCTS INC (NATR)
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live BMEA dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.